A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections

A Prospective Randomized Trial of Imipenem-Cilastatin Versus Clindamycin/Tobramycin in the Treatmentof Intra-Abdominal and Pelvic Infections

Objective: A Canadian multicentre clinical trial in the treatment of intra-abdominal and pelvic infections to compare the efficacy and safety of monotherapy using imipenem-cilastatin (imipenem) (500 mg intravenously every 6 h) versus combination therapy with clindamycin/tobramycin (clindamycin 600 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Lionel A Mandell, Pierre L Turgeon, Allan R Ronalds, The Canadian Clinical Trials Group
Format: Article
Language:English
Published: Wiley 1993-01-01
Series:Canadian Journal of Infectious Diseases
Online Access:http://dx.doi.org/10.1155/1993/567478
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items